Genetic Classification of Gliomas: Refining Histopathology

MichaelB Foote, Nickolas Papadopoulos, LuisA Diaz

Research output: Contribution to journalArticle

Abstract

Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology. Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology.

Original languageEnglish (US)
Pages (from-to)9-11
Number of pages3
JournalCancer Cell
Volume28
Issue number1
DOIs
StatePublished - Jul 13 2015

Fingerprint

Glioma
Monosomy 1p Chromosome 1

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology
  • Medicine(all)

Cite this

Genetic Classification of Gliomas : Refining Histopathology. / Foote, MichaelB; Papadopoulos, Nickolas; Diaz, LuisA.

In: Cancer Cell, Vol. 28, No. 1, 13.07.2015, p. 9-11.

Research output: Contribution to journalArticle

Foote, MichaelB ; Papadopoulos, Nickolas ; Diaz, LuisA. / Genetic Classification of Gliomas : Refining Histopathology. In: Cancer Cell. 2015 ; Vol. 28, No. 1. pp. 9-11.
@article{df4bed1f1d7c4632b791262c7f73c52d,
title = "Genetic Classification of Gliomas: Refining Histopathology",
abstract = "Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology. Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology.",
author = "MichaelB Foote and Nickolas Papadopoulos and LuisA Diaz",
year = "2015",
month = "7",
day = "13",
doi = "10.1016/j.ccell.2015.06.014",
language = "English (US)",
volume = "28",
pages = "9--11",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Genetic Classification of Gliomas

T2 - Refining Histopathology

AU - Foote, MichaelB

AU - Papadopoulos, Nickolas

AU - Diaz, LuisA

PY - 2015/7/13

Y1 - 2015/7/13

N2 - Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology. Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology.

AB - Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology. Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology.

UR - http://www.scopus.com/inward/record.url?scp=84937485443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937485443&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2015.06.014

DO - 10.1016/j.ccell.2015.06.014

M3 - Article

C2 - 26175411

AN - SCOPUS:84937485443

VL - 28

SP - 9

EP - 11

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 1

ER -